CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Sale | −202,319 | $99.61 | $20.2M | 803,964.06 |
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Sale | −96,981 | $100.22 | $9.7M | 706,983.06 |
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Sale | −700 | $101.05 | $71K | 706,283.06 |
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Gift | −1,710 | 704,573.06 | ||
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Gift | −2,450 | 702,123.06 | ||
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Gift | −1,470 | 700,653.06 | ||
| 2022-11-01 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −300,000 | 165,828 | ||
| 2022-10-31 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +300,000 | 1,006,283.06 | ||
| 2022-10-31 | FRAZIER KENNETH C Executive Chair | Sale | −70,698 | $99.82 | $7.1M | 935,585.06 |
| 2022-10-31 | FRAZIER KENNETH C Executive Chair | Sale | −229,302 | $101.03 | $23.2M | 706,283.06 |
| 2022-10-31 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −300,000 | 465,828 | ||
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +567,084 | 1,273,367.06 | ||
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −75,489 | $99.15 | $7.5M | 1,197,878.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −313,232 | $100.25 | $31.4M | 884,646.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −178,363 | $100.80 | $18.0M | 706,283.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Exercise or conversion · Stock Option (Right to Buy) | −567,084 | 0 | ||
| 2022-08-03 | FRAZIER KENNETH C Executive Chair | Grant or award · Restricted Stock Unit | +28,532 | 28,532 | ||
| 2022-05-03 | FRAZIER KENNETH C Executive Chair | Grant or award · Restricted Stock Unit | +28,703 | 28,703 | ||
| 2022-02-24 | FRAZIER KENNETH C Executive Chair | Grant or award | +119,488 | $73.51 | $8.8M | 706,283.06 |
| 2021-11-09 | FRAZIER KENNETH C Executive Chair | Exercise or conversion | +663,881 | 1,250,676.06 |
Page 2 of 3 · 43 trades